Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
Open Access
- 15 February 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (3) , e326-e328
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groupsJournal of Infection, 2022
- A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysisKidney International, 2021
- Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) dataThe Lancet HIV, 2021
- Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US VeteransJAMA Network Open, 2021
- Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United StatesClinical Infectious Diseases, 2021
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020